Speaker illustration

Doctor Yu Mi Kang

Harvard Medical School Teaching Hospital, Boston (United States of America)

Member of:

European Society of Cardiology

Cardiovascular Efficacy of Evolocumab in Patients with Obesity: Updates from FOURIER Trial

Event: ESC Congress 2024

Topic: Drug therapy

Session: Smaller trials, trial updates, and other studies on lipid therapy

Thumbnail